Intuitive Surgical (ISRG) Receives a Buy from RBC Capital
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Intuitive Surgical on April 13 and set a price target of $650.00. The company’s shares closed yesterday at $458.96.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Singh Chadha covers the Healthcare sector, focusing on stocks such as Boston Scientific, Medtronic, and Becton Dickinson. According to TipRanks, Singh Chadha has an average return of 0.0% and a 45.23% success rate on recommended stocks.
In addition to RBC Capital, Intuitive Surgical also received a Buy from BTIG’s Ryan Zimmerman in a report issued on April 13. However, on the same day, Mizuho Securities assigned a Hold rating to Intuitive Surgical (NASDAQ: ISRG).
Based on Intuitive Surgical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.87 billion and a net profit of $794.8 million. In comparison, last year the company earned a revenue of $2.41 billion and had a net profit of $685.7 million
Read More on ISRG:
Disclaimer & DisclosureReport an Issue
- Intuitive Surgical price target lowered to $525 from $575 at Mizuho
- Intuitive Surgical price target lowered to $574 from $616 at BTIG
- Intuitive Surgical price target lowered to $480 from $550 at Evercore ISI
- Private Markets: Kraken pauses IPO plans, Quince raises $500M
- IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
